Pawandeep Dhami
Wellcome Trust Sanger Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pawandeep Dhami.
American Journal of Human Genetics | 2005
Pawandeep Dhami; Alison J. Coffey; Stephen Abbs; Joris Vermeesch; Jan P. Dumanski; Karen Woodward; Robert Andrews; Cordelia Langford; David Vetrie
The development of high-throughput screening methods such as array-based comparative genome hybridization (array CGH) allows screening of the human genome for copy-number changes. Current array CGH strategies have limits of resolution that make detection of small (less than a few tens of kilobases) gains or losses of genomic DNA difficult to identify. We report here a significant improvement in the resolution of array CGH, with the development of an array platform that utilizes single-stranded DNA array elements to accurately measure copy-number changes of individual exons in the human genome. Using this technology, we screened 31 patient samples across an array containing a total of 162 exons for five disease genes and detected copy-number changes, ranging from whole-gene deletions and duplications to single-exon deletions and duplications, in 100% of the cases. Our data demonstrate that it is possible to screen the human genome for copy-number changes with array CGH at a resolution that is 2 orders of magnitude higher than that previously reported.
Genome Research | 2009
Alexander W. Bruce; Andrés J. López-Contreras; Paul Flicek; Thomas A. Down; Pawandeep Dhami; Shane C. Dillon; Christoph M. Koch; Cordelia Langford; Ian Dunham; Robert Andrews; David Vetrie
The molecular events that contribute to, and result from, the in vivo binding of transcription factors to their cognate DNA sequence motifs in mammalian genomes are poorly understood. We demonstrate that variations within the DNA sequence motifs that bind the transcriptional repressor REST (NRSF) encode in vivo DNA binding affinity hierarchies that contribute to regulatory function during lineage-specific and developmental programs in fundamental ways. First, canonical sequence motifs for REST facilitate strong REST binding and control functional classes of REST targets that are common to all cell types, whilst atypical motifs participate in weak interactions and control those targets, which are cell- or tissue-specific. Second, variations in REST binding relate directly to variations in expression and chromatin configurations of RESTs target genes. Third, REST clearance from its binding sites is also associated with variations in the RE1 motif. Finally, and most surprisingly, weak REST binding sites reside in DNA sequences that show the highest levels of constraint through evolution, thus facilitating their roles in maintaining tissue-specific functions. These relationships have never been reported in mammalian systems for any transcription factor.
PLOS ONE | 2010
Pawandeep Dhami; Peter Saffrey; Alexander W. Bruce; Shane C. Dillon; Kelly Chiang; Nicolas Bonhoure; Christoph M. Koch; Jackie Bye; Keith D. James; Nicola S. Foad; Peter Ellis; Nicholas A. Watkins; Willem H. Ouwehand; Cordelia Langford; Robert Andrews; Ian Dunham; David Vetrie
It has recently been shown that nucleosome distribution, histone modifications and RNA polymerase II (Pol II) occupancy show preferential association with exons (“exon-intron marking”), linking chromatin structure and function to co-transcriptional splicing in a variety of eukaryotes. Previous ChIP-sequencing studies suggested that these marking patterns reflect the nucleosomal landscape. By analyzing ChIP-chip datasets across the human genome in three cell types, we have found that this marking system is far more complex than previously observed. We show here that a range of histone modifications and Pol II are preferentially associated with exons. However, there is noticeable cell-type specificity in the degree of exon marking by histone modifications and, surprisingly, this is also reflected in some histone modifications patterns showing biases towards introns. Exon-intron marking is laid down in the absence of transcription on silent genes, with some marking biases changing or becoming reversed for genes expressed at different levels. Furthermore, the relationship of this marking system with splicing is not simple, with only some histone modifications reflecting exon usage/inclusion, while others mirror patterns of exon exclusion. By examining nucleosomal distributions in all three cell types, we demonstrate that these histone modification patterns cannot solely be accounted for by differences in nucleosome levels between exons and introns. In addition, because of inherent differences between ChIP-chip array and ChIP-sequencing approaches, these platforms report different nucleosome distribution patterns across the human genome. Our findings confound existing views and point to active cellular mechanisms which dynamically regulate histone modification levels and account for exon-intron marking. We believe that these histone modification patterns provide links between chromatin accessibility, Pol II movement and co-transcriptional splicing.
PLOS ONE | 2010
Pawandeep Dhami; Alexander W. Bruce; Johanna H. Jim; Shane C. Dillon; Amanda Hall; Jonathan L. Cooper; Nicolas Bonhoure; Kelly Chiang; Peter Ellis; Cordelia Langford; Robert Andrews; David Vetrie
The SCL (TAL1) transcription factor is a critical regulator of haematopoiesis and its expression is tightly controlled by multiple cis-acting regulatory elements. To elaborate further the DNA elements which control its regulation, we used genomic tiling microarrays covering 256 kb of the human SCL locus to perform a concerted analysis of chromatin structure and binding of regulatory proteins in human haematopoietic cell lines. This approach allowed us to characterise further or redefine known human SCL regulatory elements and led to the identification of six novel elements with putative regulatory function both up and downstream of the SCL gene. They bind a number of haematopoietic transcription factors (GATA1, E2A LMO2, SCL, LDB1), CTCF or components of the transcriptional machinery and are associated with relevant histone modifications, accessible chromatin and low nucleosomal density. Functional characterisation shows that these novel elements are able to enhance or repress SCL promoter activity, have endogenous promoter function or enhancer-blocking insulator function. Our analysis opens up several areas for further investigation and adds new layers of complexity to our understanding of the regulation of SCL expression.
Genome Research | 2007
Christoph M. Koch; Robert Andrews; Paul Flicek; Shane C. Dillon; Ulaş Karaöz; Gayle K. Clelland; Sarah Wilcox; David Beare; Joanna C. Fowler; Phillippe Couttet; Keith D. James; Gregory C. Lefebvre; Alexander W. Bruce; Oliver M. Dovey; Peter Ellis; Pawandeep Dhami; Cordelia Langford; Zhiping Weng; Ewan Birney; Nigel P. Carter; David Vetrie; Ian Dunham
Human Molecular Genetics | 2005
Alvaro Rada-Iglesias; Ola Wallerman; Christoph M. Koch; Adam Ameur; Stefan Enroth; Gayle K. Clelland; Kenneth Wester; Sarah Wilcox; Oliver M. Dovey; Peter Ellis; Vicki Wraight; Keith D. James; Robert Andrews; Cordelia Langford; Pawandeep Dhami; Nigel P. Carter; David Vetrie; Fredrik Pontén; Jan Komorowski; Ian Dunham; Claes Wadelius
Genomics | 2002
Dietrich A. Stephan; Gareth R. Howell; Tanya M. Teslovich; Alison J. Coffey; Lorie Smith; Joan E. Bailey-Wilson; Lindsay Malechek; Derek Gildea; Jeffrey R. Smith; Elizabeth M. Gillanders; Johanna Schleutker; Ping Hu; Helen E. Steingruber; Pawandeep Dhami; Christiane M. Robbins; Izabela Makalowska; John D. Carpten; Raman Sood; Steve Mumm; Rolland Reinbold; Tom I. Bonner; Agnes Baffoe-Bonnie; Lukas Bubendorf; Mervi Heiskanen; Olli P. Kallioneimi; Andreas D. Baxevanis; Shirin S. Joseph; Ileana Zucchi; Robert D. Burk; William B. Isaacs
Genome Research | 1999
Helen E. Steingruber; Andrew Dunham; Alison J. Coffey; S. M. Clegg; Gareth R. Howell; Gareth L. Maslen; Carol Scott; Rhian Gwilliam; Paul Hunt; Elizabeth C. Sotheran; Elizabeth J. Huckle; Sarah Hunt; Pawandeep Dhami; Cari Soderlund; M. A. Leversha; David R. Bentley; Mark T. Ross
Blood | 2007
Johanna H. Jim; Pawandeep Dhami; Amanda King; Jonathan L. Cooper; Dave Vetrie